Elaine Courtney, PA
Physician Assistant · Louisville, KYNPI 1255769097
Payments from drug & device makers
Across 104 payments — averaging $20.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$308
- Bristol Myers Squibb$259
- Sanofi-aventis U.S. LLC$156
- AbbVie$133
- Incyte Corporation$126
- Johnson & Johnson$81
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,130100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 16 | $308 |
| Bristol Myers Squibb | 13 | $259 |
| Sanofi-aventis U.S. LLC | 7 | $156 |
| AbbVie | 7 | $133 |
| Incyte Corporation | 8 | $126 |
| Johnson & Johnson | 4 | $81 |
| Gilead | 3 | $78 |
| Genentech USA, Inc. | 3 | $76 |
| Astellas Pharma US Inc | 3 | $71 |
| Genmab U.S., Inc. | 3 | $68 |
| AstraZeneca(2 entities) | 3 | $62 |
| Adaptive Biotechnologies Corporation | 3 | $58 |
| ADC Therapeutics America, Inc. | 3 | $54 |
| Beigene USA, Inc. | 2 | $53 |
| Sanofi | 2 | $44 |
| GSK | 2 | $42 |
| Puma Biotechnology, Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 1 | $35 |
| Pfizer | 2 | $33 |
| Beone Medicines USA, Inc. | 2 | $32 |
| Sobi, Inc | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Bayer | 1 | $29 |
| EUSA Pharma (US) LLC | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $24 |
| Cumberland Pharmaceuticals, Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Geron Corporation | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $15 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
| Morphosys, US Inc. | 1 | $15 |
How this compares
$2,130 in reported general payments places this provider in the 80th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 22 | $983 |
| Acyclovir | 63 | $817 |
| Potassium Chloride | 21 | $325 |
| Levofloxacin | 17 | $258 |
| Dexamethasone | 19 | $156 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $83 |
| Amlodipine Besylate | 15 | $33 |
| ClopidogrelClopidogrel Bisulfate | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Louisville
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Robert TatumLouisville$29K
- Grace IsaacsLouisville$28K
- Joshua CastlenLouisville$16K
- Erin WaggonerLouisville$14K
- Shelley SchulerLouisville$12K
- Jacquee McNearLouisville$10K
- Kylee DreisbachLouisville$9K
- Emily LutzLouisville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.